Pentixapharm Holding AG

€1.95As of Sun 8 Nov 2026, 12:00 UTC
XETRA:PTPHealthcare
Country Germany
PE (Fwd) •••
TSR 2Y CAGR (23.43%)
Div yield —
ROE (43.27%)
Biotechnology
Beta (5Y) 1.49
PE TTM —
TSR TTM 34.42%
Mkt cap €48.33M
ROIC (32.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.13
9.39%
(62.87%)
Buy 3|0|4|6|9
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.04
0.04
0.04
10.76%
20.40%
6.45%
9.90%
Revenue€M
3.361
3.417
3.382
3.282
6.97%
3.51%
3.65%
(3.08%)
Peers (US$55.65M)
Cap (US$)
PE
192.3M
—
134.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.093
0.608
0.526
EBIT/Intx
7.854
0.290
0.278
Own earn%
106.60
6.83
34.89
Sh yield%
15.68
38.27
39.63
Owners
Insiders/Inst%
13.76
25.57
Short interest%
4.87
SBC / revenue%
4.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
19–28
$1 testx
—
Incr. ROIC%
3